Medpace Holdings, a global CRO focused on drug and medical device development, filed on Friday with the SEC to raise up to $150 million in an initial public offering.
The Cincinnati, OH-based company was founded in 1992 and booked $332 million in sales for the 12 months ended March 31, 2016. It plans to list on the Nasdaq under the symbol MEDP. Medpace filed confidentially on March 15, 2016.
